Substituted aminopyridine compounds as EGFR inhibitors | Patent Publication Number 20230086884
US 20230086884 A1Patent NumberUS 11981658 B2
Application Number17822450
Filled DateAug 26, 2022
Priority DateAug 27, 2021
Publication DateMar 23, 2023
Original AssigneeJohnson & Johnson
Wuhan University Of Technology
Wuhan University Of Technology
Current AssigneeJanssen Biotech Inc.
Inventor/ApplicantsGyu Jin LEE
James Campbell ROBERTSON
Hyunjoo Lee
Jae Young Sim
Heejun KIM
Marian C. Bryan
Sol Park
Kwan Hoon Hyun
James Campbell Robertson
Su Bin CHOI
Scott KUDUK
Tae Kyun Kim
Gyu Jin Lee
Kwan Hoon HYUN
Misong Kim
Scott Kuduk
Marian C. BRYAN
Tae Kyun KIM
Su Bin Choi
Jae Young SIM
Byoungmoon Lee
Hyunjoo LEE
Young Ae YOON
Byoungmoon LEE
Heejun Kim
Young Ae Yoon
Sol PARK
Misong KIM
James Campbell ROBERTSON
Hyunjoo Lee
Jae Young Sim
Heejun KIM
Marian C. Bryan
Sol Park
Kwan Hoon Hyun
James Campbell Robertson
Su Bin CHOI
Scott KUDUK
Tae Kyun Kim
Gyu Jin Lee
Kwan Hoon HYUN
Misong Kim
Scott Kuduk
Marian C. BRYAN
Tae Kyun KIM
Su Bin Choi
Jae Young SIM
Byoungmoon Lee
Hyunjoo LEE
Young Ae YOON
Byoungmoon LEE
Heejun Kim
Young Ae Yoon
Sol PARK
Misong KIM
See the invalidated claims, subscribe to our Concierge Program.
View Concierge Program
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.